cladribine has been researched along with Malignant Melanoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; Chen, L; Chen, X; Liu, Q; Sun, S; Tang, C; Wei, Z; Xing, F; Yao, Y; Zhang, B; Zhang, Z; Zhou, C | 1 |
| Chan, DW; Chan, TK; Chiu, E; Kwong, YL; Liang, R | 1 |
| Bosly, A; Brousset, P; Delannoy, A; Pris, J; Riga-Huguet, F; Schlaifer, D | 1 |
| Beutler, E; Carrera, CJ; Carson, DA; Copeland, B; Kawasaki, H; Kosty, M; Piro, LD; Saven, A; Waltz, T; Zyroff, J | 1 |
4 other study(ies) available for cladribine and Malignant Melanoma
| Article | Year |
|---|---|
The tumor therapy landscape of synthetic lethality.
Topics: Cell Line, Tumor; Cladribine; Cyclin-Dependent Kinase Inhibitor p16; Humans; Melanoma; Models, Theoretical; Mutation; Synthetic Lethal Mutations | 2021 |
Hairy cell leukemia: treatment results and association with secondary malignancy.
Topics: China; Cladribine; Humans; Interferon-alpha; Leukemia, Hairy Cell; Melanoma; Neoplasms, Second Primary | 1995 |
Secondary neoplasms in two patients treated with purine analogues.
Topics: Acute Disease; Aged; Cladribine; Female; Humans; Immunocompromised Host; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Melanoma; Neoplasms, Second Primary; Skin Neoplasms; Vidarabine; Waldenstrom Macroglobulinemia | 1994 |
2-Chlorodeoxyadenosine dose escalation in nonhematologic malignancies.
Topics: Adult; Aged; Astrocytoma; Bone Marrow; Brain Neoplasms; Carcinoma, Renal Cell; Cladribine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasms; Nervous System | 1993 |